Home › Uterine Cancer › Illinois
Uterine Cancer clinical trials in Illinois
4 studies for Uterine Cancer are looking for participants at sites in Illinois.
Cities in Illinois
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Rush University Medical Center, Chicago
- Rush University Medical Center, Ophthalmology, Chicago
- Illinois Eye Center, Peoria
- and 1 more
RecruitingPhase 4
Ages 18 and older · Women · Updated Nov 5, 2026 · NCT06952660Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy
- Northwestern Memorial Hospital, Chicago
Recruiting
Ages 18 and older · Women · Updated Oct 15, 2026 · NCT05990426DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Arlington Heights
- Research Site, Evanston
RecruitingPhase 3
Ages 18 and older · Women · Updated Oct 13, 2026 · NCT06989112Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Chicago
- Research Site, Peoria
- Research Site, Urbana
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 29, 2026 · NCT07044336From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.